Sign In
Buy BBH
$181.73
-4.21 (-2.26%)
At Close: Jun 02, 2026
Best ETF Areas for Placing Your Bets in September
07:05pm, Friday, 03'rd Sep 2021
Let's take a look at some ETF areas that can be good investment options for September.
5 Top-Ranked ETFs That Outperformed in August
03:14pm, Thursday, 02'nd Sep 2021
Let's take a look at some top-ranked ETFs that outperformed Wall Street in August.
Biotech ETFs to Benefit From Latest Booster Update
06:18pm, Friday, 20'th Aug 2021
The U.S. government's plans to make COVID-19 vaccine booster shots available from next month will likely increase the profits of vaccine makers.
How Are Biotech ETFs Reacting to These Q2 Earnings Releases?
04:15pm, Thursday, 12'th Aug 2021
Let's take a look at some big biotechnological earnings releases to see if these will impact ETFs exposed to the space.
ETF Investing Areas to Consider for August
04:04pm, Friday, 06'th Aug 2021
Let's take a look at some ETF areas that can be good investment options for August.
Delta Variant Surge Brings Biotech ETFs in Focus
06:18pm, Tuesday, 03'rd Aug 2021
The biotech sector seems like a lucrative investment space as the delta variant of coronavirus continues to spread.
Mostly Sanguine Regulatory Outlook for Biotech, Healthcare Names
02:03pm, Friday, 30'th Jul 2021
A change in leadership in the Oval Office often stirs talk about the regulatory environment for the healthcare sector. That talk is often elevated when one party controls the presidency and both house
Time for Pharma and Healthcare ETFs?
02:34pm, Friday, 23'rd Jul 2021
The broader medical sector should gain on decent earnings expectations and higher COVID-19-related sales
2 Sector ETFs Hovering Around All-Time Highs
02:29pm, Thursday, 22'nd Jul 2021
The U.S. economic backdrop and investors' sentiments have remained mixed in recent weeks.
Will Biotech ETFs Benefit from Biogen's New Alzheimer's Drug?
09:54am, Wednesday, 09'th Jun 2021
Biotech investors may have reason to celebrate this week, as the FDA approved Biogen's Alzheimer's disease drug Aducanumab on Monday, ushering in the first medication to be allowed by U.S. regulators
Top COVID-19 Vaccine Stories of May Put Biotech ETFs in Focus
04:32pm, Tuesday, 01'st Jun 2021
Let's take a look at some top coronavirus vaccine stories of May and the possible impact they can have on biotech ETFs.
Biotech ETFs to Suffer as US Backs IP Waiver for COVID-19 Vaccines
06:02pm, Friday, 07'th May 2021
The Biden administration recently informed about supporting the waiver of intellectual property protections for COVID-19 vaccines that has been proposed by South Africa and India.
Top COVID-19 Vaccine Stories of April Put Biotech ETFs in Focus
04:32pm, Tuesday, 04'th May 2021
Let's take a look at some top coronavirus vaccine stories of April and the possible impact they can have on biotech ETFs.
Biotech Innovations Remain At Forefront
11:10am, Friday, 16'th Apr 2021
The first quarter of 2021 was challenging for the biotechnology industry, as the selloff in March represented a sharp reversal from record highs in February. While the sector has remained relatively r
Moving Beyond COVID In Biopharma
09:31am, Thursday, 15'th Apr 2021
Just over one year after COVID-19 disrupted our lives, we are now getting to the point where multiple vaccine options are nearly ubiquitous for those in the United States. Per the CDC, as of April 12,
